Providing a diverse range of perspectives from bullish to bearish, 12 analysts have published ratings on Allstate ALL in the last three months.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 6 | 1 | 2 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 1 | 0 | 1 | 0 |
| 3M Ago | 3 | 4 | 1 | 1 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $183.0, along with a high estimate of $200.00 and a low estimate of $146.00. This current average reflects an increase of 6.67% from the previous average price target of $171.55.
Diving into Analyst Ratings: An In-Depth Exploration
A comprehensive examination of how financial experts perceive Allstate is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Meyer Shields | Keefe, Bruyette & Woods | Maintains | Outperform | $194.00 | $194.00 |
| Elyse Greenspan | Wells Fargo | Raises | Underweight | $153.00 | $146.00 |
| Jimmy Bhullar | JP Morgan | Raises | Overweight | $193.00 | $185.00 |
| Michael Phillips | Morgan Stanley | Raises | Overweight | $190.00 | $187.00 |
| Elyse Greenspan | Wells Fargo | Raises | Underweight | $146.00 | $145.00 |
| Oliver Wintermantel | Evercore ISI Group | Raises | In-Line | $173.00 | $166.00 |
| Meyer Shields | Keefe, Bruyette & Woods | Raises | Outperform | $189.00 | $181.00 |
| Jimmy Bhullar | JP Morgan | Raises | Overweight | $185.00 | $172.00 |
| Harry Fong | Roth MKM | Raises | Buy | $200.00 | $175.00 |
| Paul Newsome | Piper Sandler | Raises | Overweight | $188.00 | $172.00 |
| Vikram Gandhi | HSBC | Announces | Buy | $190.00 | - |
| Alex Scott | Goldman Sachs | Raises | Buy | $195.00 | $164.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Allstate. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Allstate compared to the broader market.
- Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.
For valuable insights into Allstate's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Allstate analyst ratings.
Discovering Allstate: A Closer Look
Allstate is one of the largest US property and casualty insurers in the US. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 10,000 company agencies.
Allstate: Delving into Financials
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Allstate's remarkable performance in 3 months is evident. As of 31 March, 2024, the company achieved an impressive revenue growth rate of 10.68%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Allstate's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 7.79%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Allstate's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 7.34% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Allstate's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.14%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Allstate's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.48, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
How Are Analyst Ratings Determined?
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
